{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:03:08Z","timestamp":1768633388988,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FUNADERSP","award":["28\/2015"],"award-info":[{"award-number":["28\/2015"]}]},{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2013-23277-8"],"award-info":[{"award-number":["2013-23277-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2014\/509443-1"],"award-info":[{"award-number":["2014\/509443-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["465682\/2014-6"],"award-info":[{"award-number":["465682\/2014-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["88887.136405\/2017-06"],"award-info":[{"award-number":["88887.136405\/2017-06"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p><jats:italic>BRCA1<\/jats:italic> associated-protein 1 (<jats:italic>BAP1<\/jats:italic>) tumor predisposition syndrome is associated with an increased risk for malignant mesotheliomas, uveal and cutaneous melanomas, renal cell carcinomas, and singular cutaneous lesions. The latter are referred to as <jats:italic>BAP1<\/jats:italic>-inactivated melanocytic tumors (BIMTs). When multiple BIMTs manifest, they are considered potential markers of germline <jats:italic>BAP1<\/jats:italic> mutations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>Here, we report a novel pathogenic <jats:italic>BAP1<\/jats:italic> germline variant in a family with a history of BIMTs, cutaneous melanomas, and mesotheliomas. We also describe singular pathological aspects of the patient\u2019s BIMT lesions and their correlation with dermoscopic and reflectance confocal microscopy findings.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This knowledge is crucial for the recognition of BIMTs by dermatologists and pathologists, allowing the determination of appropriate management for high-risk patients, such as genetic investigations and screening for potentially aggressive tumors.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-019-6226-8","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T16:03:00Z","timestamp":1573315380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy"],"prefix":"10.1186","volume":"19","author":[{"given":"Bianca Costa","family":"Soares de S\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Petaccia","family":"de Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovana Tardin","family":"Torrezan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Casagrande Tavoloni","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Fidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Facure","family":"Moredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rute","family":"Lellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Pereira","family":"Duprat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5667-1418","authenticated-orcid":false,"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"6226_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10:179.","journal-title":"J Transl Med"},{"key":"6226_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejca.2017.12.022","volume":"92","author":"P Star","year":"2018","unstructured":"Star P, Goodwin A, Kapoor R, Conway RM, Long GV, Scolyer RA, et al. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy. Eur J Cancer. 2018;92:48\u201353.","journal-title":"Eur J Cancer"},{"issue":"12","key":"6226_CR3","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/jnci\/djy171","volume":"110","author":"S Walpole","year":"2018","unstructured":"Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, et al. Comprehensive study of the clinical phenotype of Germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst. 2018 Dec 1;110(12):1328\u201341.","journal-title":"J Natl Cancer Inst"},{"key":"6226_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011;43:1018\u201321.","journal-title":"Nat Genet"},{"key":"6226_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","volume":"36","author":"T Wiesner","year":"2012","unstructured":"Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36:818\u201330.","journal-title":"Am J Surg Pathol"},{"key":"6226_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035295","volume":"7","author":"CN Njauw","year":"2012","unstructured":"Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012;7:e35295.","journal-title":"PLoS One"},{"key":"6226_CR7","volume-title":"WHO classification of skin tumors","year":"2018","unstructured":"Elder DE, Massi D, Scolyer RA, Willemze R, editors. WHO classification of skin tumors. 4th ed. Lyon: IARC; 2018.","edition":"4"},{"key":"6226_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamadermatol.2017.2330","volume":"153","author":"AM Haugh","year":"2017","unstructured":"Haugh AM, Njauw CN, Bubley JA, Verz\u00ec AE, Zhang B, Kudalkar E, et al. Genotypic and phenotypic features of BAP1 Cancer syndrome: a report of 8 new families and review of cases in the literature. JAMA Dermatol. 2017;153:999\u20131006.","journal-title":"JAMA Dermatol"},{"key":"6226_CR9","doi-asserted-by":"crossref","unstructured":"Zhang AJ, Rush PS, Tsao H, Duncan LM. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors. J Cutan Pathol. 2019;24:1\u20138.","DOI":"10.1111\/cup.13530"},{"issue":"4","key":"6226_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/bjd.16740","volume":"179","author":"S Moawad","year":"2018","unstructured":"Moawad S, Reigneau M, de la Fouchardi\u00e8re A, Soufir N, Schmutz JL, Granel-Brocard F, et al. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus\/tumour in two familial cases of BAP1 syndrome. Br J Dermatol. 2018 Oct;179(4):973\u20135.","journal-title":"Br J Dermatol"},{"issue":"6","key":"6226_CR11","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jaad.2018.09.014","volume":"80","author":"O Y\u00e9lamos","year":"2019","unstructured":"Y\u00e9lamos O, Navarrete-Dechent C, Marchetti MA, Rogers T, Apalla Z, Bahadoran P, et al. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: results of multicenter case-control study by the international Dermoscopy society. J Am Acad Dermatol. 2019 Jun;80(6):1585\u201393.","journal-title":"J Am Acad Dermatol"},{"key":"6226_CR12","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cup.12493","volume":"42","author":"Z Maru\u0161i\u0107","year":"2015","unstructured":"Maru\u0161i\u0107 Z, Buljan M, Busam KJ. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. J Cutan Pathol. 2015;42:406\u201312.","journal-title":"J Cutan Pathol"},{"key":"6226_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. And ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"6226_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.sder.2009.06.005","volume":"28","author":"I Zalaudek","year":"2009","unstructured":"Zalaudek I, Manzo M, Savarese I, Docimo G, Ferrara G, Argenziano G. The morphologic universe of melanocytic nevi. Semin Cutan Med Surg. 2009;28:149\u201356.","journal-title":"Semin Cutan Med Surg"},{"key":"6226_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jaad.2005.08.022","volume":"53","author":"G Pellacani","year":"2005","unstructured":"Pellacani G, Cesinaro AM, Seidenari S. Reflectance-mode confocal microscopy of pigmented skin lesions--improvement in melanoma diagnostic specificity. J Am Acad Dermatol. 2005;53:979\u201385.","journal-title":"J Am Acad Dermatol"},{"key":"6226_CR16","doi-asserted-by":"crossref","unstructured":"Tavoloni Braga JC, de Paula Ramos Castro R, Moraes pinto Blumetti TC, Rocha Mendes FB, Ar\u00eaas de Souza Lima Beltrame Ferreira J, Rezze GG. Opening a window into living tissue: Histopathologic features of confocal microscopic findings in skin tumors. Dermatol Clin 2016; 34:377\u2013394.","DOI":"10.1016\/j.det.2016.05.002"},{"key":"6226_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.humpath.2014.10.015","volume":"46","author":"A Piris","year":"2015","unstructured":"Piris A, Mihm MC Jr, Hoang MP. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Hum Pathol. 2015;46:239\u201345.","journal-title":"Hum Pathol"},{"issue":"3","key":"6226_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jaad.2018.05.005","volume":"79","author":"EM Garfield","year":"2018","unstructured":"Garfield EM, Walton KE, Quan VL, VandenBoom T, Zhang B, Kong BY, Isales MC, Panah E, et al. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors. J Am Acad Dermatol. 2018 Sep;79(3):525\u201334.","journal-title":"J Am Acad Dermatol"},{"key":"6226_CR19","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, et al. The genetic evolution of melanoma from precursor lesions. N Engl J Med. 2015;373:1926\u201336.","journal-title":"N Engl J Med"},{"key":"6226_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","volume":"45","author":"R Murali","year":"2013","unstructured":"Murali R, Wiesner T, Scolyer RA. Tumours associated with BAP1 mutations. Pathology. 2013;45:116\u201326.","journal-title":"Pathology."},{"key":"6226_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/DAD.0b013e31829fdcd7","volume":"36","author":"V Kazlouskaya","year":"2014","unstructured":"Kazlouskaya V, Guo Y, Maia-Cohen S, Mones J. Clear-cell melanocytic lesions with balloon-cell and sebocyte-like melanocytes: a unifying concept. Am J Dermatopathol. 2014;36:380\u20136.","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"6226_CR22","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","volume":"46","author":"SM McGregor","year":"2015","unstructured":"McGregor SM, Dunning R, Hyjek E, Vigneswaran W, Husain AN, Krausz T. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma. Hum Pathol. 2015 Nov;46(11):1670\u20138.","journal-title":"Hum Pathol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6226-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:26:48Z","timestamp":1604795208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6226"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6226-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present report has been approved by the Ethics Committee of our institution (2076\/15). Written consent forms were obtained from both the patient and her sister.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent forms were obtained from both the patient and her sister.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1077"}}